Skip to main content
. 2022 Oct 12;12:444. doi: 10.1038/s41398-022-02207-2

Table 1.

Details of MRI studies investigating candidate predictive/prognostic biomarkers for treatment response.

Authors, year Country N ADHD N Controls Age % Male % White Design Candidate biomarker(s) Key findings
Griffiths et al. [20] Australia 37 (19 had taken psychostimulants in the previous 6-months, and underwent a washout period) 26 M = 13.29 SD = 2.64 70% Not reported 6-week open label study of MPH, pre-treatment neuroimaging White matter local efficiency (graph theoretical measure of how efficiently information can be distributed between a brain region and its neighbors) Support vector machine learning algorithm applied to multivariate measures of local efficiency predict treatment response assessed at 6-weeks using the ADHD-RS-IV. The most predictive features were higher local efficiency of the thalamus, precentral gyrus and DLPFC.
Hong et al. [24] South Korea 83 (medication-free for >4 weeks, and with no history of long-term treatment for ADHD, defined as medicated >6 months) 22 M = 9.63 SD = 2.61 25% Not reported 8-week RCT of MPH, pre-treatment neuroimaging Resting-state connectivity assessed using striatal seeds Treatment responders (n = 48), defined according to the CGI-I at 8-weeks, showed greater pre-treatment connectivity between striatal seeds and orbitofrontal, cingulo-opercular and middle and medial temporal regions than did non-responders.
Kim et al. [18] South Korea 67 (medication-free for >4 weeks, and with no history of long-term treatment for ADHD, defined as medicated >6 months) 25 M = 9.83 SD = 2.5 25% Not reported 8-week RCT of MPH, pre-treatment neuroimaging Subcortical volume Responders had smaller volumes in bilateral amygdala and hippocampal subregions and right thalamus than non-responders.
Lam et al. [29] UK 31 (24 subjects were receiving stable medication) 0 M = 13.90 SD = 1.58 100% Not reported 2-week real-time fMRI neurofeedback of the right IFG vs. neurofeedback of a control para-hippocampal region. Single-blind RCT Brain activation during inhibitory control task as a predictor of neurofeedback learning Better neurofeedback learning was associated with pre-treatment activation in left IFG/insula and striatum during the fMRI stop task.
Mizuno et al. [83] Japan 27 (all medication-free for >5 times half-lives) 49 M = 10.96, SD = 2.14 100% Not reported Double-blind, placebo-controlled, crossover design comparing single-dose MPH and placebo Dynamic resting-state functional connectivity Dynamic network interactions under placebo predicted individual differences in sustained attention improvements under MPH.
Moreno et al. [19] Spain 27 (all treatment naïve) 0 M = 9.33 SD = 2.49 70% Not reported 4-week open-label trial of MPH, pre-treatment neuroimaging Subcortical gray matter concentration Treatment responders, as defined via clinical interview and administration of CGI and CGAS, showed greater gray matter concentration within the nucleus accumbens and caudate compared with non-responders.
Norman et al. [22] USA 110 (medicated) 142 age range, 6–17 years 65% Not reported

Naturalistic longitudinal study of chronically medicated subjects, including up to 5 assessments.

Scanning was performed during washout period.

Resting-state connectivity within and between cingulo-opercular, default mode and subcortical networks was assessed while subjects were off medication. ADHD symptoms were rated on and off medication using the DICA-IV interview for parents. Non-responders showed developmentally atypical increases in cingulo-opercular connectivity with age, while responders showed a developmental trajectory that tracked that of the controls.
Peterson et al. [21] USA 16 (psychostimulant responders) 20 M = 13.71 SD = 2.85 69% 94% Non-blinded study of chronically medicated psychostimulant responders with ADHD. Subjects were scanned on and off medication Brain activation was assessed during a stop task both on and off medication Off-medication left lateral prefrontal cortex activation correlated with differences in total ADHD symptoms, which were assessed using on and off medication versions of the CPRS in youth with ADHD.
Schulz et al. [27] USA 36 (medication-naïve) 0 M = 11.0 SD = 2.4 83% Not reported 8-week MPH/ATX randomized cross-over design, pre-treatment Brain activation during a go/no-go task Greater pre-treatment caudate activation was associated with a better treatment response to MPH, but a worse response to ATX, as assessed using ADHD-RS-IV.

ADHD attention deficit hyperactivity disorder, ADHD-RS-IV ADHD Rating Scale-IV, ATX atomoxetine, CGAS Children’s Global Assessment Scale, CGI Clinical Global Impressions scale, CPRS Conners’ Parent Rating Scale, DICA-IV Diagnostic Interview for Children and Adolescents – IV; fMRI functional magnetic resonance imaging; IFG inferior prefrontal gyrus, MPH methylphenidate, MRI magnetic resonance imaging, RCT randomized controlled trial.